Pneumonia
From the Journals
Pneumococcal pneumonia outcomes worse than those of Legionnaires disease
From the Journals
Pneumonia decision tool reduces death in ED patients
“This was a clear demonstration that these best practices made the biggest difference in patients who were sick and who did not have any...
Latest News
Nirsevimab protects healthy infants from RSV
“Nirsevimab has the potential to seriously decrease the annual overwhelming number of RSV infected babies.”
News from the FDA/CDC
Legionnaires’ disease shows steady increase in U.S. over 15+ years
News from the FDA/CDC
CDC issues new pneumococcal vaccine recommendations for adults
PCV15 and PREVNAR20 received approval from the FDA in July 2021, providing an impetus for the revised recommendations.
Latest News
Severe outcomes increased in youth hospitalized after positive COVID-19 test
Older age, underlying illness, and symptom duration were associated with increased risk of severe outcomes.
From the Journals
Pediatric community-acquired pneumonia: 5 days of antibiotics better than 10 days
“These data are immediately applicable to frontline clinicians,” said Dr. Derek Williams of Vanderbilt University.
Latest News
Pneumonia in infancy predicts respiratory problems in early childhood
“Lower respiratory tract infections during the first years of life cause injury to the rapidly developing lung at its most critical stage.”
From the Journals
Ceftolozane-tazobactam found effective in critically ill patients with Pseudomonas aeruginosa infections
The primary outcome of the study was to assess the efficacy and toxicity of C/T therapy.
Conference Coverage
Potentially practice-changing bacterial therapy trials analyzed
Conference Coverage
Flu and pneumonia vaccination tied to lower dementia risk
These preliminary data suggest that vaccination against both respiratory illnesses may lower the risk for cognitive decline and dementia.